Utah Medical Products, Inc.
UTMD
$64.51
-$0.48-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.43% | -5.83% | -12.35% | -16.64% | -19.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.43% | -5.83% | -12.35% | -16.64% | -19.92% |
| Cost of Revenue | -3.48% | -1.43% | -8.73% | -13.27% | -18.55% |
| Gross Profit | -5.11% | -8.88% | -14.89% | -18.99% | -20.88% |
| SG&A Expenses | 14.73% | 12.75% | 3.22% | -15.12% | -23.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.12% | 2.32% | -5.89% | -14.25% | -19.84% |
| Operating Income | -15.54% | -18.86% | -22.59% | -20.59% | -20.07% |
| Income Before Tax | -15.31% | -16.03% | -19.71% | -17.65% | -19.76% |
| Income Tax Expenses | -10.99% | -3.59% | 1.63% | -7.68% | -14.39% |
| Earnings from Continuing Operations | -16.28% | -18.65% | -23.83% | -19.68% | -20.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.28% | -18.65% | -23.83% | -19.68% | -20.87% |
| EBIT | -15.54% | -18.86% | -22.59% | -20.59% | -20.07% |
| EBITDA | -12.55% | -15.16% | -20.00% | -22.41% | -25.82% |
| EPS Basic | -10.54% | -11.94% | -17.33% | -13.76% | -16.34% |
| Normalized Basic EPS | -9.21% | -11.52% | -16.26% | -14.58% | -14.71% |
| EPS Diluted | -10.57% | -11.95% | -17.33% | -13.67% | -16.18% |
| Normalized Diluted EPS | -9.21% | -11.51% | -16.25% | -14.53% | -14.59% |
| Average Basic Shares Outstanding | -6.36% | -7.52% | -7.77% | -6.86% | -5.51% |
| Average Diluted Shares Outstanding | -6.36% | -7.52% | -7.77% | -6.93% | -5.65% |
| Dividend Per Share | 1.65% | 1.66% | 1.67% | 1.67% | 1.68% |
| Payout Ratio | 0.13% | 0.15% | 0.24% | 0.19% | 0.23% |